Patients News | pharmaphorum

News

CRISPR biotech Intellia plummets as trial paused for safety

Intellia lost 45% of its value today as phase 3 trials of one of its priority drug programmes were halted due to a patient being hospitalised.

News

A male HCP discusses treatment with an older male patient

Bayer's prostate cancer drug Nubeqa cleared for NHS use

Thousands of men living with incurable prostate cancer will be able to access an easier-to-tolerate treatment from Bayer, thanks to new NICE guidance.

News

ICER says US new drug launch prices have risen sharply

ICER says the prices of new drug launches in the US rose 51% in three years, adding up to $1.5bn in first-year costs to US health systems.

News

UK start-up Procyon has pancreatic cancer test in its sights

Procyon is hoping to launch a diagnostic test next year that will be able to detect people at risk of pancreatic cancer from a urine sample.

News

GSK will file oral carbapenem for complicated UTIs this year

GSK and Spero's cabapenem tebipenem is the first oral antibiotic in the class to show efficacy in complicated urinary tract infections.

News

Joy as retinal implant restores sight in geographic atrophy

A wireless retinal implant already filed for approval has been shown to restore vision in patients with eye disease geographic atrophy.

CRISPR biotech Intellia plummets as trial paused for safety

Bayer's prostate cancer drug Nubeqa cleared for NHS use

ICER says US new drug launch prices have risen sharply

UK start-up Procyon has pancreatic cancer test in its sights

GSK will file oral carbapenem for complicated UTIs this year

Joy as retinal implant restores sight in geographic atrophy

Threat of Trump's pharma tariffs looms again

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks